Intelligence Platform

Patents

Browse 72 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 8163703

Hepatitis C therapies

BioCryst Pharmaceuticals, Inc. · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8133870

Therapeutic furopyrimidines and thienopyrimidines

BioCryst Pharmaceuticals, Inc. · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994139

Antiviral therapeutic agents

BioCryst Pharmaceuticals, Inc. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7514410

Hepatitis C therapies

BioCryst Pharmaceuticals, Inc. · Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429571

Therapeutic furopyrimidines and thienopyrimidines

BioCryst Pharmaceuticals, Inc. · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7388002

Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases

BioCryst Pharmaceuticals, Inc. · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7045535

Compounds useful for inhibiting paramyxovirus neuraminidase

BioCryst Pharmaceuticals, Inc. · Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6946554

Process for the preparation of 9-deazaguanine derivatives

BioCryst Pharmaceuticals, Inc. · Granted Tue Sep 20 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6936719

Biaryl compounds as serine protease inhibitors

BioCryst Pharmaceuticals, Inc. · Granted Tue Aug 30 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6835326

Fluorescent ink compositions comprising functionalized fluorescent nanocrystals

BioCrystal, Ltd. · Granted Tue Dec 28 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6762032

Compositions, assay kits, and methods for use related to a disease condition comprising mu

BioCrystal, Ltd. · Granted Tue Jul 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6699994

Biaryl compounds as serine protease inhibitors

BioCryst Pharmaceuticals, Inc. · Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6680211

Fluorescent nanocrystal-embedded microspheres for fluorescence analysis

BioCrystal, Ltd. · Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6660719

Inhibiting T-Cell proliferation

BioCryst Pharmaceuticals, Inc. · Granted Tue Dec 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6656915

Inhibiting T-cell proliferation

BioCryst Pharmaceuticals, Inc. · Granted Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6576786

Process for preparing substituted cyclopentane derivatives and novel crystalline structure

BioCryst Pharmaceuticals, Inc. · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6576155

Fluorescent ink compositions comprising functionalized fluorescent nanocrystals

BioCrystal, Ltd. · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6562861

Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors

BioCryst Pharmaceuticals, Inc. · Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6458799

Deazaguanine analog, preparation thereof and use thereof

BioCryst Pharmaceuticals, Inc. · Granted Tue Oct 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6410594

Substituted cyclopentane compounds useful as neuraminidase inhibitors

BioCryst Pharmaceuticals, Inc. · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6387923

Imminoribitol PNP inhibitors, preparation thereof and use thereof

BioCryst Pharmaceuticals, Inc. · Granted Tue May 14 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6268350

Polynucleotides for inhibiting metastasis and tumor cell growth

BioCrystal, Ltd. · Granted Tue Jul 31 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6245752

Compositions and methods for tolerization in immune complex-mediated disease progression

BioCrystal, Ltd. · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6224866

Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors

BioCrystal, Ltd. · Granted Tue May 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)